Sign in
Taking people in South KoreaNo phase

Wearable cuffless blood pressure monitor to guide care in uncontrolled hypertension

Tests a wearable cuffless monitor to guide treatment in adults with uncontrolled hypertension.

Key facts

Who runs it
Korea University Anam Hospital
Where
Ansan and Seoul, South KoreaSee the 3 sites
Trial code
Registry title
CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension
Status
Recruiting
People taking part
400 people, planned
Started
22 Oct 2025
Expected to end
31 Jul 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CART BP Pro
  • Usual Care
Record updated
12 November 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age ≥ 19 years
  • Uncontrolled hypertension defined as office systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg
  • Ability and willingness to provide written informed consent and comply with study procedures

Who cannot take part

  • History of intolerance or contraindication to olmesartan, amlodipine, or hydrochlorothiazide
  • Suspected secondary hypertension
  • Any serious medical condition that may interfere with study participation or interpretation of study results
  • Atrial fibrillation
  • Pregnancy or lactation

Where in South Korea

  • Korea University Ansan HospitalAnsan, South KoreaContact: Seung Yong Shin, MD PhDTaking people
  • Korea University Anam HospitalSeoul, South KoreaContact: Hyung Joon JooTaking people
  • Korea University Guro HospitalSeoul, South KoreaContact: Soohyung Park, MD PhDTaking people

About the trial

What the trial wants to find out

This multicenter, prospective, open-label randomized trial compares CART BP Pro-guided blood pressure management with usual care based on office blood pressure in Korean adults with uncontrolled hypertension. The planned enrollment is 400 participants at three Korea University hospitals. Participants are assigned in a 1:1 ratio to the two groups. CART BP Pro is a ring-type device that estimates blood pressure from optical pulse signals. Both groups receive guideline-based antihypertensive care.

Read full original descriptionShow less

The main outcome is the difference between groups in CART-derived, time-weighted 24-hour mean systolic blood pressure at the 24-week assessment, with an allowable assessment window of 16-32 weeks. Both groups undergo outcome assessment. Recording-quality rules allow some incomplete recordings, including early device return, while requiring sufficient duration and time coverage. Standardized office blood pressure, office blood pressure below 130/80 mmHg, other CART blood pressure measures, and adverse events are also assessed.

The 2 groups in the trial

  • CART BP Pro-guided blood pressure managementTreatment being tested

    Participants will undergo ambulatory blood pressure monitoring using the CART BP Pro wearable device. Antihypertensive medication adjustments will be guided by ambulatory blood pressure data obtained from the device.

    Treatment: CART BP Pro

  • Usual careExisting treatment, for comparison

    Participants will receive standard hypertension management based on office blood pressure measurements according to current clinical guidelines.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management Compared With Usual Care in Korean Patients With Uncontrolled Hypertension: A Multicenter Prospective Randomized Controlled Trial
Plain-language title
Wearable cuffless blood pressure monitor to guide care in uncontrolled hypertensionGenerated from the registry record. The registry title is the official one.
Record updated
12 November 2026